IgD myeloma. Report of a case with unusual clinical and immunologic features.
暂无分享,去创建一个
R. Tubbs | S. Govindarajan | S. Deodhar | R. Bukowski | R. Valenzuela | SharadD. Deodhar | Sugantha Govindarajan | Raymond R. Tubbs | R. Bukowski | Rafael Valenzuela
[1] S. Pemmaraju,et al. IgD myeloma with myelofibrosis and amyloidosis. , 1977, Archives of pathology & laboratory medicine.
[2] W. Pruzanski,et al. Kappa and lambda light chain disease: survival rates and clinical manifestations , 1976 .
[3] S. Salmon,et al. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.
[4] W. Pruzanski,et al. IgD Multiple Myeloma: Review of 133 Cases , 1975 .
[5] H. Wilson,et al. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. , 1969, JAMA.
[6] J. Rubini,et al. D-Myeloma: Report of Two Cases , 1967 .
[7] D. Bergsagel,et al. Myeloma Proteins and the Clinical Response to Melphalan Therapy , 1965, Science.
[8] J. Fahey,et al. A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD. , 1965 .
[9] J. Fahey,et al. A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN. , 1965 .